GenBioPro, a leading manufacturer of abortion medication, is preparing to go to battle with the Trump administration.

Limiting mifepristone access, changing Title X rules and implementation of the Emergency Medical Treatment and Labor Act are ...

The industry could see payment, workforce and insurance coverage changes depending on how the Trump administration weighs in ...

In a letter obtained by the Associated Press, 21 technologists at the U.S. Digital Service, lamely rebranded by Donald Trump ...

The Biden administration clarified that EMTALA requires hospitals to perform abortions when they are the necessary treatment to stabilize a patient, but the policy’s future is uncertain.

President Donald Trump’s executive order to expand access to in vitro fertilization doesn’t immediately change any policy, ...

Mehmet Oz, M.D., says he will divest from insurance, provider and drugmakers if he earns confirmation from the Senate to run ...

Universities, now slated to face sweeping cuts in agency grants that cover these overhead costs, say the policy will destroy ongoing and future biomedical science.

The 922-page playbook compiled by the Heritage Foundation, a conservative research group in Washington, says "the NIH ...